The company said stockholders approved at the April 30, 2026 annual meeting an amendment to the Amended 2010 Plan that raises the number of shares reserved for issuance from 120,350,000 to 125,350,000 and extends the plan's term to January 29, 2036.

1. 01

   The company said stockholders approved at the April 30, 2026 annual meeting an amendment to the Amended 2010 Plan that raises the number of shares reserved for issuance from 120,350,000 to 125,350,000 and extends the plan's term to January 29, 2036.

2. 02

   Intuitive Surgical said the amendment and restatement of its Amended and Restated 2010 Incentive Award Plan (Proposal No. 4) was approved, with 260,005,547 votes for, 22,129,032 against, 1,056,767 abstentions and 29,960,297 broker non-votes.

3. 03

   The company said all 10 director nominees were elected at the annual meeting. It said the advisory vote on executive compensation (Proposal No. 2) was approved, with 265,030,878 votes for and 17,018,702 against.

4. 04

   Intuitive Surgical said on April 30, 2026 its board increased the authorized amount under the stock repurchase program to $5.0 billion in total, including amounts remaining under the prior authorization. The company said it expects to fund the program with cash, cash equivalents and investments, and said it is not obligated to repurchase any particular amount of stock.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.